SBH Sciences News
April 4, 2013
Procognia and SBH Sciences Join forces to Offer Services to Biotech Industry
October 10, 2012
Woodland and SBH Sciences Announce New Incubator Model
to support IND-enabling Preclinical Efficacy Studies for Novel Oncology Molecules
Galectin Therapeutics Announces Relocation of Corporate Headquarters to Atlanta, GA, while maintaining the excellent work being done by our Collaborators at SBH Sciences.
NEWTON, MA Aug. 31, 2012 Galectin Therapeutics Announces Relocation of Corporate Headquarters to Atlanta, GA while the Boston area location will continue product development and analysis, cell culture models of drug action and the development of analytical tools for complex carbohydrate drugs. The Boston area laboratory effort will be located at SBH Sciences in Natick, MA, where the Company has had a long-term relationship, and will be led by Dr. Eliezer Zomer, the Senior Vice President for Manufacturing and Development.
Read full press release
SBH Sciences Celebrates its 15-Year Anniversary
A Full Spectrum Of Preclinical Oncology Services is Enabled by the New Strategic Partnership of SBH Sciences and Woodland Oncology Services.
June 19, 2012
Governor Patrick and Israeli Chief Scientist Avi Hasson
Announce First Round of Massachusetts-Israel Innovation Partnership
Grants at Biotechnology Industry Organization (BIO) Convention
Video and Text of the speech given by Raphael Nir, President of SBH Sciences, during the Massachusetts-Israel Innovation Partnership (MIIP) event.
June 14-18, 2012
COVIDIEN, Organix and SBH Sciences are presenting a poster in World Congress of Interventional Oncology (WCIO)
April 30, 2012
SBH Sciences and Cell Assay Innovations
Announce an Agreement to Provide Kinase Cell-based Screening Services
October 24, 2011
SBH Sciences Registered with CLIA
December 18, 2009
pION Biopharma Services & SBH Sciences Announces
Caco-2 Permeability Measurement